ValiRx plc (AIM:VAL)
London · Delayed Price · Currency is GBP · Price in GBX 0.1600
0.00 (0.00%)
Aug 14, 2026, 4:22 PM GMT
ValiRx Market Cap
ValiRx has a market cap or net worth of 2.11 million as of August 14, 2026. Its market cap has increased by 7.49% in one year.
Market Cap
2.11M
Enterprise Value
863.75K
Revenue
31.37K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.16
ChartMarket Cap Chart
Since October 3, 2006, ValiRx's market cap has decreased from 12.83M to 2.11M, a decrease of -83.54%. That is a compound annual growth rate of -8.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 2.11M | -15.10% |
| Dec 31, 2025 | 2.49M | -14.24% |
| Dec 31, 2024 | 2.90M | -51.94% |
| Dec 29, 2023 | 6.04M | -33.71% |
| Dec 30, 2022 | 9.11M | -61.38% |
| Dec 31, 2021 | 23.58M | 86.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Solvonis Therapeutics | 10.21M |
| Cizzle Biotechnology Holdings | 7.01M |
| OptiBiotix Health | 5.94M |
| CRISM Therapeutics | 5.83M |
| Thalia Therapeutics | 5.62M |
| Oxford BioDynamics | 5.58M |
| Theracryf | 4.19M |
| Nuformix | 3.52M |